The ongoing COVID‐19 pandemic caused by SARS‐CoV‐2 is associated with high
morbidity and mortality. This zoonotic virus has emerged in Wuhan of China in December …

Since its discovery in 2019, multiple variants of severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) have been identified. This study investigates virus spread and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encodes several proteins
that inhibit host interferon responses. Among these, ORF6 antagonizes interferon signaling …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an exceptionally
transmissible and pathogenic coronavirus that appeared at the end of 2019 and triggered a …

SARS-CoV-2 variants of concern (VOC) have triggered infection waves. Oral antivirals such
as molnupiravir promise to improve disease management, but efficacy against VOC delta …

In vitro, ACE2 translocates to the nucleus to induce SARS-CoV-2 replication. Here, using
digital spatial profiling of lung tissues from SARS-CoV-2-infected golden Syrian hamsters …

For coronavirus disease 2019 (COVID-19), effective and well-understood treatment options
are still scarce. Since vaccine efficacy is challenged by novel variants, short-lasting …

Vitamin D supplementation is linked to improved outcomes from respiratory virus infection,
and the COVID-19 pandemic renewed interest in understanding the potential role of vitamin …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to evolve
throughout the coronavirus disease-19 (COVID-19) pandemic, giving rise to multiple …

Detection of secretory antibodies in the airway is highly desirable when evaluating mucosal
protection by vaccines against a respiratory virus, such as the severe acute respiratory …